Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.

Saved in:
Bibliographic Details
Title: Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.
Authors: Yang, Ming‐Han1 (AUTHOR), Huang, Chiun‐Sheng2,3 (AUTHOR), Chang, Dwan‐Ying1 (AUTHOR), Hu, Fu‐Chang4,5 (AUTHOR), Huang, Shu‐Min1 (AUTHOR), Huang, Po‐Hsiang1 (AUTHOR), Chen, I‐Chun1,6,7 (AUTHOR), Chen, Tom Wei‐Wu1,7 (AUTHOR), Lin, Ching‐Hung1,3,6 (AUTHOR), Lu, Yen‐Shen1,3 (AUTHOR) yslu@ntu.edu.tw
Source: Cancer Medicine. Jul2024, Vol. 13 Issue 14, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 178684075
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yang%2C+Ming‐Han%22">Yang, Ming‐Han</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Chiun‐Sheng%22">Huang, Chiun‐Sheng</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang%2C+Dwan‐Ying%22">Chang, Dwan‐Ying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Fu‐Chang%22">Hu, Fu‐Chang</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Shu‐Min%22">Huang, Shu‐Min</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Po‐Hsiang%22">Huang, Po‐Hsiang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+I‐Chun%22">Chen, I‐Chun</searchLink><relatesTo>1,6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Tom+Wei‐Wu%22">Chen, Tom Wei‐Wu</searchLink><relatesTo>1,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Ching‐Hung%22">Lin, Ching‐Hung</searchLink><relatesTo>1,3,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Yen‐Shen%22">Lu, Yen‐Shen</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> yslu@ntu.edu.tw</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Jul2024, Vol. 13 Issue 14, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178684075
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.70005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang, Ming‐Han
      – PersonEntity:
          Name:
            NameFull: Huang, Chiun‐Sheng
      – PersonEntity:
          Name:
            NameFull: Chang, Dwan‐Ying
      – PersonEntity:
          Name:
            NameFull: Hu, Fu‐Chang
      – PersonEntity:
          Name:
            NameFull: Huang, Shu‐Min
      – PersonEntity:
          Name:
            NameFull: Huang, Po‐Hsiang
      – PersonEntity:
          Name:
            NameFull: Chen, I‐Chun
      – PersonEntity:
          Name:
            NameFull: Chen, Tom Wei‐Wu
      – PersonEntity:
          Name:
            NameFull: Lin, Ching‐Hung
      – PersonEntity:
          Name:
            NameFull: Lu, Yen‐Shen
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: Jul2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20457634
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Cancer Medicine
              Type: main
ResultId 1